We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

First-of-Its-Kind Synthetic DNA Vaccine Tested Against Powassan Virus

News   Nov 02, 2020 | Original story from the Wistar Institute

 
First-of-Its-Kind Synthetic DNA Vaccine Tested Against Powassan Virus

Powassan virus is a tick-borne, emerging infectious disease. Credit: The Wistar Institute.

 
 
Advertisement
 

RELATED ARTICLES

Key Questions and Answers About the UK's First Approved COVID-19 Vaccine

News

The UK government has announced that the COVID-19 vaccine BNT162b2 – developed by Pfizer and BioNTech – has been authorized for use. Here, we address some of the key questions you may have about this announcement.

READ MORE

New Lab-on-Chip Infection Test Could Enable Cheaper, Faster Portable Diagnostics

News

A tiny new silicon-based lab-on-chip test could pave the way for cheap handheld infectious disease testing. The chip, developed at Imperial College London and known as TriSilix, is a ‘micro laboratory’ which performs a miniature version of the polymerase chain reaction (PCR) on the spot.

READ MORE

Metabolic State of a Parasite Influences Its Resistance to Drugs

News

A new study has established that the parasite that causes chagas disease can be influenced by azole drugs, depending on its own metabolic state.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE